GSK acquires private vaccine maker and Merck spin-off Okairos for €250mm
For €250mm ($325mm) in cash, GlaxoSmithKline PLC has acquired private vaccine maker Okairos AG.
- Gene Therapy, Cell Therapy
- Large Molecule
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.